EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of Glomerular Filtration Rate on Potentially Inappropriate Medications in Older Adults: A Cross‐Sectional Study

Qingmin Yao, Yanxia Liu, Ting Yuan, Wen Zhang, Yahui Zhang, Wen Chen, Xiaojuan Zhu, Jianchun Wang

Journal of Clinical Pharmacy and Therapeutics · 2026-01 · 2026 (1)

DOI: 10.1155/jcpt/6682398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical Pharmacy and Therapeutics, online erschienen am 22.07.2026. Verfasst von Qingmin Yao und 7 weiteren Autor:innen. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Natural Science Foundation of Shandong Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aimed to assess the association between estimated glomerular filtration rate (eGFR) levels and the prevalence of potentially inappropriate medications (PIMs) based on three criteria: the Beers (2019 version), Chinese, and Screening Tool of Older Persons’ Prescriptions (STOPP) criteria.

Methods

This retrospective cross‐sectional study analyzed 191 inpatients aged ≥ 65 years. Using the Beers, Chinese, and STOPP criteria, we assessed the prevalence of PIMs across stratified eGFR levels. Nonparametric analyses (Mann–Whitney U test), chi‐square tests, and logistic regression analysis were employed to evaluate the association between eGFR and PIMs exposure.

Results

Participants were stratified into three groups based on eGFR: Group I (≥ 90 mL/min/1.73 m 2 ), Group II (60–89 mL/min/1.73 m 2 ), and Group III (< 60 mL/min/1.73 m 2 ). Prevalence rates of PIMs were 72.25% by Beers criteria, 60.73% by Chinese criteria, and 28.80% by STOPP criteria, with STOPP demonstrating significantly lower PIMs detection rates than the other two criteria. Analysis by eGFR stratification revealed escalating PIMs prevalence with declining kidney function under Beers criteria: 67.35% in Group I, 74.29% in Group II, and 86.96% in Group III ( p < 0.05). Notably, Group III (eGFR < 60 mL/min/1.73 m 2 ) exhibited higher proportions of patients with ≥ 2 PIMs across all criteria. By Beers criteria, 56.52% of Group III patients had ≥ 2 PIMs versus 22.45% (Group I) and 25.71% (Group II). Similar trends were observed by Chinese and STOPP criteria ( p < 0.05). Logistic regression analysis identified polypharmacy and eGFR decline as independent risk factors for PIMs exposure.

Conclusion

The prevalence of PIMs gradually increases with the decline of eGFR in older adults, particularly when compounded by polypharmacy.

Förderung

  • National Key Research and Development Program of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Yao, Q., Liu, Y., Yuan, T., Zhang, W., Zhang, Y., Chen, W., Zhu, X., & Wang, J. (2026). Influence of Glomerular Filtration Rate on Potentially Inappropriate Medications in Older Adults: A Cross‐Sectional Study. Journal of Clinical Pharmacy and Therapeutics, 2026(1). https://doi.org/10.1155/jcpt/6682398

Vancouver

Yao Q, Liu Y, Yuan T, Zhang W, Zhang Y, Chen W, et al. Influence of Glomerular Filtration Rate on Potentially Inappropriate Medications in Older Adults: A Cross‐Sectional Study. Journal of Clinical Pharmacy and Therapeutics. 2026;2026(1). doi:10.1155/jcpt/6682398

BibTeX
@article{Yao2026,
  author = {Yao, Qingmin and Liu, Yanxia and Yuan, Ting and Zhang, Wen and Zhang, Yahui and Chen, Wen and Zhu, Xiaojuan and Wang, Jianchun},
  title = {Influence of Glomerular Filtration Rate on Potentially Inappropriate Medications in Older Adults: A Cross‐Sectional Study},
  journal = {Journal of Clinical Pharmacy and Therapeutics},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jcpt/6682398}
}
Kostenlos starten →